Unlock instant, AI-driven research and patent intelligence for your innovation.

Runx3 gene showing Anti-tumor activity and use thereof

a technology of runx3 and anti-tumor activity, applied in the field of runx3 gene, can solve the problems of difficult to discriminate between these types, concomitant significant side effects, and killing some normal cells, and achieve the effect of reducing the expression of runx3

Inactive Publication Date: 2008-10-23
BAE SUK CHUL +1
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention is about a gene called RUNX3 and its role in cancer development. The inventors found that the RUNX3 gene has tumor suppressor activity and is important for inducing cell death. They also discovered that inactivation of the RUNX3 gene by DNA methylation is closely correlated with cancer. The invention provides a cell strain with over-expressed or inhibited expression of the RUNX3 gene, as well as a pharmaceutical composition and uses of the gene and its proteins in developing anticancer agents and diagnostic methods.

Problems solved by technology

Tumors are assemblies of cells that show excessive autonomous proliferation, and are classified into malignant tumors, which may result in death, and benign tumors; however, it can be difficult to discriminate between these types.
However, these anticancer agents suffer from the disadvantage of also killing some normal cells, such as immune cells and hair root cells, with concomitant significant side effects; they are thus not able to be used for long periods of time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Runx3 gene showing Anti-tumor activity and use thereof
  • Runx3 gene showing Anti-tumor activity and use thereof
  • Runx3 gene showing Anti-tumor activity and use thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Establishment of the SNU16-Rx3-AS and MKN28-Rx3 Cell Strains

[0084]To elucidate the function of the RUNX3 gene in vivo, cell strains capable of over-expressing a sense RUNX3 gene and an antisense RUNX3: gene were established as follows.

1-1 Construction of Expression Plasmid Vectors Containing Sense and Antisense RUNX3 Genes

[0085]The human RUNX3 gene cloned by the present inventors in 1995 (Bae et al., Gene, 159 (2):245-248, 1995; cDNA nucleotide sequence GenBank Accession No. Z35278) was used to construct plasmid vectors capable of expressing RUNX3. The cDNA of the RUNX3 gene has the nucleotide sequence SEQ. ID. NO: 1 with an open reading frame ranging from the translation start codon to the translation stop codon, which encodes a polypeptide consisting of 415 amino acids whose putative amino acid sequence is SEQ. ID. NO: 2 (FIGS. 1a to 1c). A DNA fragment comprising CpG islands present in the vicinity of exon 1 of the RUNX3 gene has the nucleotide sequence SEQ. ID. NO: 3 (FIGS. 2a a...

example 2

Cell Death Effect of TGF-β and Role of the RUNX3 Gene in TGF-β-Induced Cell Death

2-1 Cell Death Effect of TGF-β

[0094]SNU16 cells, which normally express the RUNX3 gene, and SNU16-Rx3-AS-c11 and SNU16-Rx3-AS-c12 cells in which an antisense RUNX3 cDNA is over-expressed to selectively inhibit the expression of the normal RUNX3 gene, were individually treated with TGF-β1 (1 ng / ml), after which viable cells were counted over a period of time. The results are shown in FIG. 4a.

[0095]As seen in FIG. 4a, the TGF-β1 treatment induced cell death in SNU16 cells. Almost all SNU16 cells were killed within 2 days after treatment with TGF-β1 at a concentration of 1 ng / ml. However, the SNU16-Rx3-AS-c11 cells, in which the antisense RUNX3 gene was excessively expressed to selectively inhibit the expression of the RUNX3 gene, were not killed after treatment with TGF-β1. These results suggest that the RUNX3 gene is involved in TGF-β1-induced cell death in SNU16 cells.

2-2 Role of RUNX3 Gene in TGF-β In...

example 3

Suppressive Activity of RUNX3 Against Tumorigenicity

[0099]It is known that TGF-β1-induced apoptosis is a very important mechanism for suppressing the progression of normal cells toward cancer and that most of the factors in the TGF-β1 pathway have tumor suppressor activity. The RUNX3 gene was assayed for tumor suppressor activity using nude mice, with the expectation that an anticancer effect would be seen.

[0100]To this end, the SNU16-Rx3-AS-c11 and SNU16-Rx3-AS-c12 strains, in which RUNX3 gene expression is selectively inhibited and the control-SUN16 strain were suspended in 0.85% phosphate buffered saline (PBS) at a density of 3×107 cells / ml, and 0.3 ml of each suspension was subcutaneously injected into groups of nude mice. Separately, the MKN28-Rx3 strain that shows over-expression of the sense RUNX3 RNA and the control-MKN28 strain were suspended in 0.85% PBS at a density of 5×107 cells / ml, and 0.3 ml of each suspension was subcutaneously injected into other groups of nude mice...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a RUNX3 gene showing anti-tumor activity which is essentially involved in TGF-β-dependent programmed cell death (apoptosis) and use thereof. In addition, the present invention finds that RUNX3 gene expression is suppressed in the various gastric cancer and lung cancer cell lines. The suppression of the RUNX3 gene expression is due to hyper-methylation of CpG islands located around RUNX3 exon 1. The RUNX3 gene and its gene product of the present invention can be used effectively for the development of anti-cancer agents. The CpG islands around RUNX3 exon 1 could also be used not only for the development of anti-cancer agents which regulate the abnormal DNA methylation and thereby induce RUNX3 expression, and also for the development of methods for cancer diagnosis by measuring the abnormal DNA methylation.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This application is a divisional application of U.S. patent application Ser. No. 10 / 466,938 filed Jul. 18, 2003, which in turn claims a benefit of priority from Korean Patent Application No. 2001-4018 filed Jan. 29, 2001 through PCT Application Serial No. PCT / KR01 / 00121 filed Jan. 30, 2001, the contents of each of which are incorporated herein by reference.FIELD OF THE INVENTION[0002]The present invention relates to the RUNX3 gene and uses thereof as an anticancer agent. More specifically, the present invention relates to characterization of the RUNX3 gene, its expression and tumor suppressor activity, and its use in the development of cancer diagnosis methods and anticancer agents.BACKGROUND OF THE INVENTION[0003]Tumors are assemblies of cells that show excessive autonomous proliferation, and are classified into malignant tumors, which may result in death, and benign tumors; however, it can be difficult to discriminate between these types...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/00A61K31/70A61P11/00G01N33/53A61K38/55A61K48/00A61P35/00C07K14/47C12N5/10C12N15/00C12N15/12C12Q1/68G01N33/566G01N33/574
CPCC07K14/4747A61P11/00A61P35/00C12N15/11
Inventor BAE, SUK-CHULITO
Owner BAE SUK CHUL